These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7700944)

  • 21. Cortical modulation of striatal function.
    Scatton B; Worms P; Lloyd KG; Bartholini G
    Brain Res; 1982 Jan; 232(2):331-43. PubMed ID: 6200179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of ageing on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxic effects on striatum and brainstem in the rat.
    Desole MS; Esposito G; Enrico P; Miele M; Fresu L; De Natale G; Miele E; Grella G
    Neurosci Lett; 1993 Sep; 159(1-2):143-6. PubMed ID: 8264957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Asymmetrical orientation to edges of an openfield: modulation by striatal dopamine and relationship to motor asymmetries in the rat.
    Sullivan RM; Fraser A; Szechtman H
    Brain Res; 1994 Feb; 637(1-2):114-8. PubMed ID: 8180788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apomorphine enantiomers' effects on dopamine metabolism: receptor and non-receptor related actions.
    Saller CF; Salama AI
    Eur J Pharmacol; 1986 Feb; 121(2):181-8. PubMed ID: 3699091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of vinpocetine effects on DA and DOPAC release in striatal isolated nerve endings.
    Trejo F; Nekrassov V; Sitges M
    Brain Res; 2001 Aug; 909(1-2):59-67. PubMed ID: 11478921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroprotective and neurotrophic effect of apomorphine in the striatal 6-OHDA-lesion rat model of Parkinson's disease.
    Yuan H; Sarre S; Ebinger G; Michotte Y
    Brain Res; 2004 Nov; 1026(1):95-107. PubMed ID: 15476701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitory effects of ascorbic acid on dopamine uptake by rat striatal synaptosomes: relationship to lipid peroxidation and oxidation of protein sulfhydryl groups.
    Morel P; Fauconneau B; Page G; Mirbeau T; Huguet F
    Neurosci Res; 1998 Oct; 32(2):171-9. PubMed ID: 9858024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebral astrocytes transport ascorbic acid and dehydroascorbic acid through distinct mechanisms regulated by cyclic AMP.
    Siushansian R; Tao L; Dixon SJ; Wilson JX
    J Neurochem; 1997 Jun; 68(6):2378-85. PubMed ID: 9166731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intraneostriatal administration of glutamate antagonists increases behavioral activation and decreases neostriatal ascorbate via nondopaminergic mechanisms.
    Pierce RC; Rebec GV
    J Neurosci; 1993 Oct; 13(10):4272-80. PubMed ID: 8105039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A cholinergic input to the substantia nigra pars compacta increases striatal dopamine metabolism measured by in vivo voltammetry.
    Hernández-López S; Góngora-Alfaro JL; Martínez-Fong D; Aceves J
    Brain Res; 1992 Dec; 598(1-2):114-20. PubMed ID: 1486473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pergolide potentiates L-DOPA-induced dopamine release in rat striatum after lesioning with 6-hydroxydopamine.
    Dethy S; Laute MA; Damhaut P; Goldman S
    J Neural Transm (Vienna); 1999; 106(2):145-58. PubMed ID: 10226935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of allopurinol on striatal dopamine, ascorbate and uric acid during an acute morphine challenge: ex vivo and in vivo studies.
    Enrico P; Esposito G; Mura MA; Migheli R; Serra PA; Desole MS; Miele E; De Natale G; Miele M
    Pharmacol Res; 1997 Jun; 35(6):577-85. PubMed ID: 9356212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of chronic continuous versus intermittent levodopa treatments on striatal and extrastriatal D1 and D2 dopamine receptors and dopamine uptake sites in the 6-hydroxydopamine lesioned rat--an autoradiographic study.
    Gnanalingham KK; Robertson RG
    Brain Res; 1994 Mar; 640(1-2):185-94. PubMed ID: 8004447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biochemical and behavioral effects of serotonin neurotoxins on the nigrostriatal dopamine system: comparison of injection sites.
    Giambalvo CT; Snodgrass SR
    Brain Res; 1978 Sep; 152(3):555-66. PubMed ID: 308384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fetal mesencephalic grafts influence the dopamine release in the non-lesioned striatum of 6-OHDA-lesioned rats: a behavioral and in vivo voltammetric study.
    Reum T; Morgenstern R
    Neurosci Lett; 1994 May; 173(1-2):172-6. PubMed ID: 7936408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of triadimefon on extracellular dopamine, DOPAC, HVA and 5-HIAA in adult rat striatum.
    Gagnaire F; Micillino JC
    Toxicology; 2006 Jan; 217(2-3):91-104. PubMed ID: 16246478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of brain-derived neurotrophic factor and neurotrophin-3 on neurochemical and behavioral deficits associated with partial nigrostriatal dopamine lesions.
    Altar CA; Boylan CB; Fritsche M; Jones BE; Jackson C; Wiegand SJ; Lindsay RM; Hyman C
    J Neurochem; 1994 Sep; 63(3):1021-32. PubMed ID: 7519657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of apomorphine and bradykinin on uptake and release of dopamine in vitro by striatal synaptosomes of the rat.
    Borawska M; Wiśniewski K
    Pol J Pharmacol Pharm; 1982; 34(1-3):79-84. PubMed ID: 7167424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopaminergic and serotonergic function following isolation rearing in rats: study of behavioural responses and postmortem and in vivo neurochemistry.
    Jones GH; Hernandez TD; Kendall DA; Marsden CA; Robbins TW
    Pharmacol Biochem Behav; 1992 Sep; 43(1):17-35. PubMed ID: 1384071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toluene induces behavioral activation without affecting striatal dopamine metabolism in the rat: behavioral and microdialysis studies.
    Kondo H; Huang J; Ichihara G; Kamijima M; Saito I; Shibata E; Ono Y; Hisanaga N; Takeuchi Y; Nakahara D
    Pharmacol Biochem Behav; 1995 May; 51(1):97-101. PubMed ID: 7617740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.